Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2020 Full year and fourth quarter results announcement
We will announce our full year and fourth quarter 2020 results at 12:00 GMT, 07:00 EST on Wednesday 3 February 2021.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, Iain Mackay, CFO, and Dr Hal Barron, Chief Scientific Officer and President of R&D, at 14:00 GMT, 09:00 EST.
Press releases for media
- ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe
- Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
- GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration
- ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe
GSK Twitter
-
GSK @GSK
👋 from#GI211! We are excited to join scientists, clinicians and patient advocates in the#oncologyy community to share how we’re advancing science for better patient care. What are you most excited to learn about at this year’s symposium?
about 13 hours ago -
GSK @GSK
After a strong 2020, our Chief Scientific Officer & R&D President Hal Barron shared more about how we are poised for 2021 at #JPM2021.
about 1 day ago
